Fengbo Tan
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Cells and Metastasis
- Colorectal Cancer Surgical Treatments
Papers in
- Oncology 22
- Colorectal Cancer Surgical Treatments 7
- Pancreatic and Hepatic Oncology Research 4
-
- RNA modifications and cancer 6
- Co-authors
- Qian Pei (25 shared papers)Haiping Pei (20 shared papers)Haiping Pei (9 shared papers)Yan Huang (10 shared papers)Yuqiang Li (31 shared papers)Zhongyi Zhou (21 shared papers)Hong Zhu (13 shared papers)Zhiping Hu (5 shared papers)
- Journals
- Aging (5 papers)Journal of Cancer (4 papers)Oncotarget (4 papers)Frontiers in Oncology (4 papers)Cancer Management and Research (4 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Fengbo Tan
68 papers receiving 1.3k citations
Fengbo Tan's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 254
- Oncology 313
- Gastroenterology 43
- Cell Biology 121
- Molecular Medicine 32
Countries citing papers authored by Fengbo Tan
This map shows the geographic impact of Fengbo Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengbo Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengbo Tan more than expected).
Fields of papers citing papers by Fengbo Tan
This network shows the impact of papers produced by Fengbo Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengbo Tan. The network helps show where Fengbo Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengbo Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Curcumin-primed olfactory mucosa-derived mesenchymal stem cells mitigate cerebral ischemia/reperfusion injury-induced neuronal PANoptosis by modulating microglial polarization Hit paper breakdown → | 2024 | 125 |
| 2 | 2021 | 87 | |
| 3 | 2017 | 55 | |
| 4 | 2018 | 55 | |
| 5 | 2021 | 55 | |
| 6 | 2020 | 50 | |
| 7 | 2019 | 48 | |
| 8 | 2019 | 45 | |
| 9 | Extracellular matrix stiffness regulates colorectal cancer progression via HSF4 Hit paper breakdown → | 2025 | 45 |
| 10 | 2020 | 45 | |
| 11 | 2022 | 42 | |
| 12 | 2021 | 39 | |
| 13 | 2016 | 35 | |
| 14 | 2017 | 32 | |
| 15 | 2020 | 25 | |
| 16 | 2018 | 25 | |
| 17 | 2019 | 25 | |
| 18 | 2015 | 25 | |
| 19 | 2020 | 25 | |
| 20 | 2022 | 24 |
About Fengbo Tan
Fengbo Tan is a scholar working on Oncology, Molecular Biology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 69 papers that have together received 1.3k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (9 papers), Colorectal Cancer Surgical Treatments (7 papers), Gastric Cancer Management and Outcomes (6 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (6 papers), Colorectal and Anal Carcinomas (5 papers), Sarcoma Diagnosis and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Cancer Research (254 citations), Oncology (313 citations), Gastroenterology (43 citations), Cell Biology (121 citations) and Molecular Medicine (32 citations). Fengbo Tan has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Qian Pei, Haiping Pei, Haiping Pei, Yan Huang, Yuqiang Li, Zhongyi Zhou, Hong Zhu, Zhiping Hu, Chenglong Li and Xiangping Song. Their work appears in journals such as Aging, Journal of Cancer, Oncotarget, Frontiers in Oncology and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.